- Patent Title: Anti-VEGF protein compositions and methods for producing the same
-
Application No.: US17378362Application Date: 2021-07-16
-
Publication No.: US11440950B2Publication Date: 2022-09-13
- Inventor: Matthew Franklin
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Kramer Levin Naftalis & Frankel LLP
- Agent Stephen J. Gaudet
- Main IPC: C07K14/00
- IPC: C07K14/00 ; C12N15/00 ; C07K14/71 ; C12P21/06 ; C07K1/113 ; C07K1/16 ; C07K1/36 ; C12N5/00 ; C07K1/18 ; C07K1/22 ; C12P21/02 ; A61K38/18 ; C07K16/28 ; C12N15/66 ; C07K16/22 ; G01N30/80 ; G01N30/02

Abstract:
The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.
Public/Granted literature
- US20220009997A1 ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME Public/Granted day:2022-01-13
Information query